Ann Hynes
Stock Analyst at Mizuho
(4.29)
# 381
Out of 4,944 analysts
258
Total ratings
61.83%
Success rate
10.94%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Outperform | $328 → $510 | $468.00 | +8.97% | 3 | Jul 25, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $190 → $225 | $190.23 | +18.28% | 13 | Jul 25, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $173 → $225 | $176.29 | +27.63% | 16 | Jul 25, 2025 | |
| THC Tenet Healthcare | Maintains: Outperform | $184 → $194 | $171.87 | +12.88% | 15 | Jul 11, 2025 | |
| MOH Molina Healthcare | Maintains: Outperform | $400 → $330 | $161.21 | +104.70% | 9 | Jul 11, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $8 → $7 | $7.84 | -10.71% | 4 | Jul 11, 2025 | |
| CNC Centene | Maintains: Neutral | $71 → $40 | $27.07 | +47.77% | 8 | Jul 11, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $515 → $350 | $271.81 | +28.77% | 18 | May 16, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $37 → $32 | $20.77 | +54.11% | 11 | May 14, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $178 → $189 | $179.04 | +5.56% | 15 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $305 → $316 | $281.99 | +12.06% | 8 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $455 → $505 | $294.43 | +71.52% | 4 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $175 → $155 | $155.00 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $76 | $65.90 | +15.33% | 10 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $18 | $12.67 | +42.07% | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $15.50 | -3.23% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $148.12 | -18.98% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $20 | $22.39 | -10.67% | 1 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $22.86 | +22.48% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $119.04 | -20.19% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $287.10 | +34.10% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $178.51 | +12.04% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.95 | +13,643.59% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $663.17 | -23.85% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $272.54 | -15.61% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $390.46 | -29.57% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $11.89 | +110.26% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $23.56 | +112.22% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.63 | +3,396.93% | 1 | Sep 21, 2017 |
Medpace Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $328 → $510
Current: $468.00
Upside: +8.97%
IQVIA Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $190.23
Upside: +18.28%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $176.29
Upside: +27.63%
Tenet Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $184 → $194
Current: $171.87
Upside: +12.88%
Molina Healthcare
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $161.21
Upside: +104.70%
Fortrea Holdings
Jul 11, 2025
Maintains: Neutral
Price Target: $8 → $7
Current: $7.84
Upside: -10.71%
Centene
Jul 11, 2025
Maintains: Neutral
Price Target: $71 → $40
Current: $27.07
Upside: +47.77%
UnitedHealth Group
May 16, 2025
Maintains: Outperform
Price Target: $515 → $350
Current: $271.81
Upside: +28.77%
Acadia Healthcare Company
May 14, 2025
Maintains: Neutral
Price Target: $37 → $32
Current: $20.77
Upside: +54.11%
Quest Diagnostics
Apr 9, 2025
Maintains: Outperform
Price Target: $178 → $189
Current: $179.04
Upside: +5.56%
Apr 9, 2025
Maintains: Outperform
Price Target: $305 → $316
Current: $281.99
Upside: +12.06%
Apr 9, 2025
Maintains: Outperform
Price Target: $455 → $505
Current: $294.43
Upside: +71.52%
Apr 9, 2025
Maintains: Neutral
Price Target: $175 → $155
Current: $155.00
Upside: -
Apr 9, 2025
Maintains: Outperform
Price Target: $70 → $76
Current: $65.90
Upside: +15.33%
Apr 9, 2025
Maintains: Outperform
Price Target: $19 → $18
Current: $12.67
Upside: +42.07%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $15.50
Upside: -3.23%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $148.12
Upside: -18.98%
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $22.39
Upside: -10.67%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $22.86
Upside: +22.48%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $119.04
Upside: -20.19%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $287.10
Upside: +34.10%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $178.51
Upside: +12.04%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.95
Upside: +13,643.59%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $663.17
Upside: -23.85%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $272.54
Upside: -15.61%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $390.46
Upside: -29.57%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $11.89
Upside: +110.26%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $23.56
Upside: +112.22%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.63
Upside: +3,396.93%